David Krempa

Chief Business Officer · Eton Pharmaceuticals

David Krempa (Chief Business Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Eton Pharmaceuticals, Inc. (ETON). The largest single filing was $3.2M of ETON (99,481 sh across 4 lots, as filed), executed May 22. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.1M

shares × price, as filed

Last traded

Oct 6

Filed Oct 6

Median ADV $33.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

ETON

Eton Pharmaceuticals, Inc. ETON · 0 buys · 4 sells 4 filings

Recent filings

ETONSALE Eton Pharmaceuticals, Inc. View filing → $229K
4,166 sh × $55.07
Exec Oct 6
Filed Oct 6 · 4:49 PM ET ETONSALE Eton Pharmaceuticals, Inc. View filing → $1.6M
25,000 sh × $65.07
Exec Aug 24
Filed Aug 24 · 5:19 PM ET ETONSALE Eton Pharmaceuticals, Inc. View filing → $3.2M
99,481 sh across 4 lots
Exec May 22
Filed May 27 · 5:30 PM ET ETONSALE Eton Pharmaceuticals, Inc. View filing → $504K
34,000 sh across 3 lots
Exec Jun 12 2025
Filed Jun 16 2025 · 5:30 PM ET